A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip Komarnitsky, MD
AVEO Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigational Site 1
Shatin N.T., Hong Kong
- Investigational Site 10
Kuala Lumpur, Malaysia
- Investigational Site 9
Kuala Lumpur, Malaysia
- Investigational Site 11
Kuala Pahang, Malaysia
- Investigational Site 12
Manila, Philippines
- Investigational Site 13
Pasig, Philippines
- Investigational Site 14
Quezon City, Philippines
- Investigational Site 15
Singapore, Singapore
- Investigational Site 2
Chungcheongbuk-do, South Korea
- Investigational Site 3
Gyeonggi-do, South Korea
- Investigational Site 4
Jeollanam-do, South Korea
- Investigational Site 5
Seoul, South Korea
- Investigational Site 6
Seoul, South Korea
- Investigational Site 7
Seoul, South Korea
- Investigational Site 8
Seoul, South Korea
- Investigational Site 16
Changhua, Taiwan
- Investigational Site 17
Chiayi City, Taiwan
- Investigational Site 18
Taichung, Taiwan
- Investigational Site 19
Tainan, Taiwan
- Investigational Site 20
Taipei, Taiwan
- Investigational Site 21
Taipei, Taiwan
- Investigational Site 22
Taoyuan, Taiwan
- Investigational Site 23
Bangkok, Thailand
- Investigational Site 24
Chiang Mai, Thailand
- Investigational Site 25
KhonKaen, Thailand
- Investigational Site 26
Songkhla, Thailand
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2009
- Primary completion
- 31 Aug 2013
- Completion
- 31 Aug 2013
- Last update posted
- 8 Apr 2015
- Registered enrollment
- 203
- Registry id
- NCT01039948
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.